Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Decibel Therapeutics Inc stock (Decibel Therapeutics Inc)

Buy Decibel Therapeutics Inc stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Decibel Therapeutics Inc is a biotechnology business based in the US. Decibel Therapeutics Inc shares (DBTX) are listed on the NASDAQ and all prices are listed in US Dollars. Decibel Therapeutics Inc employs 68 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Decibel Therapeutics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

Our pick for investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Decibel Therapeutics Inc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DBTX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Decibel Therapeutics Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Robinhood
Finder Score: 4.4 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Decibel Therapeutics Inc stock price (NASDAQ: DBTX)

Use our graph to track the performance of DBTX stocks over time.

Decibel Therapeutics Inc shares at a glance

Information last updated 2023-11-19.
Latest market close$4.91
52-week range$4.88 - $5.21
50-day moving average $4.61
200-day moving average $3.77
Wall St. target price$10.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.54

Is it a good time to buy Decibel Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Decibel Therapeutics Inc price performance over time

Historical closes compared with the close of $4.91 from 2023-10-04

1 week (2024-08-27) N/A
1 month (2024-08-03) N/A
3 months (2024-06-03) N/A
6 months (2024-03-03) N/A
1 year (2023-09-07) -4.10%
2 years (2022-09-07) -4.47%
3 years (2021-09-07) 8.15
5 years (2019-09-03) N/A

Decibel Therapeutics Inc financials

Gross profit TTM $0
Return on assets TTM -32.65%
Return on equity TTM -76.76%
Profit margin 0%
Book value $2.12
Market Capitalization $123.4 million

TTM: trailing 12 months

Decibel Therapeutics Inc share dividends

We're not expecting Decibel Therapeutics Inc to pay a dividend over the next 12 months.

Decibel Therapeutics Inc share price volatility

Over the last 12 months, Decibel Therapeutics Inc's shares have ranged in value from as little as $4.88 up to $5.21. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Decibel Therapeutics Inc's is -0.4025. This would suggest that Decibel Therapeutics Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Decibel Therapeutics Inc has bucked the trend.

To put Decibel Therapeutics Inc's beta into context you can compare it against those of similar companies.

Decibel Therapeutics Inc overview

Decibel Therapeutics, Inc. , a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. The company's product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. Its lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. The company is also developing DB-ATO and AAV. 201, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the vestibule; DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial; AAV. 103 to restore hearing in individuals with a gap junction beta-2 (GJB2) deficiency; AAV.

Frequently asked questions

null
What percentage of Decibel Therapeutics Inc is owned by insiders or institutions?
Currently 13.355% of Decibel Therapeutics Inc shares are held by insiders and 61.95% by institutions.
How many people work for Decibel Therapeutics Inc?
Latest data suggests 68 work at Decibel Therapeutics Inc.
When does the fiscal year end for Decibel Therapeutics Inc?
Decibel Therapeutics Inc's fiscal year ends in December.
Where is Decibel Therapeutics Inc based?
Decibel Therapeutics Inc's address is: 1325 Boylston Street, Boston, MA, United States, 02215
What is Decibel Therapeutics Inc's ISIN number?
Decibel Therapeutics Inc's international securities identification number is: US24343R1068

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site